The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Novel Oral Anticoagulants Drugs Market Research Report 2025
Synopsis
Anticoagulant drugs (also known as blood thinners) are chemical substances that prevent or reduce coagulation of blood and prolong the blood clotting time.
The global Novel Oral Anticoagulants Drugs market was valued at US$ 21420 million in 2023 and is anticipated to reach US$ 42200 million by 2030, witnessing a CAGR of 10.2% during the forecast period 2024-2030.
The antithrombotic treatment market is driven by the increasing prevalence of cardiovascular diseases and the rising aging population, which are significant risk factors for thrombotic disorders. Antithrombotic therapies, including antiplatelet and anticoagulant drugs, play a crucial role in preventing and treating thrombotic events, such as heart attacks and strokes. The growing adoption of these treatments for various thrombotic indications, along with advancements in drug development and personalized medicine, further propel market growth. However, challenges include balancing the risk of bleeding complications with the benefits of preventing thrombotic events, ensuring optimal dosing and adherence to treatment regimens, and addressing the cost burden of long-term therapy. Overcoming these challenges through continuous research, improved patient education, and collaboration between healthcare providers and pharmaceutical companies will be crucial for the sustained growth of the antithrombotic treatment market.
This report aims to provide a comprehensive presentation of the global market for Novel Oral Anticoagulants Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Novel Oral Anticoagulants Drugs.
Report Scope
The Novel Oral Anticoagulants Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Novel Oral Anticoagulants Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Novel Oral Anticoagulants Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bristol-Myers Squibb
Bayer
Pfizer
Johnson & Johnson
Boehringer Ingelheim
Daiichi Sankyo
Segment by Type
Direct Thrombin Inhibitor
Factor Xa Inhibitors
Segment by Application
Hospital
Drugs Stores
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Novel Oral Anticoagulants Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Anticoagulant drugs (also known as blood thinners) are chemical substances that prevent or reduce coagulation of blood and prolong the blood clotting time.
The global Novel Oral Anticoagulants Drugs market was valued at US$ 21420 million in 2023 and is anticipated to reach US$ 42200 million by 2030, witnessing a CAGR of 10.2% during the forecast period 2024-2030.
The antithrombotic treatment market is driven by the increasing prevalence of cardiovascular diseases and the rising aging population, which are significant risk factors for thrombotic disorders. Antithrombotic therapies, including antiplatelet and anticoagulant drugs, play a crucial role in preventing and treating thrombotic events, such as heart attacks and strokes. The growing adoption of these treatments for various thrombotic indications, along with advancements in drug development and personalized medicine, further propel market growth. However, challenges include balancing the risk of bleeding complications with the benefits of preventing thrombotic events, ensuring optimal dosing and adherence to treatment regimens, and addressing the cost burden of long-term therapy. Overcoming these challenges through continuous research, improved patient education, and collaboration between healthcare providers and pharmaceutical companies will be crucial for the sustained growth of the antithrombotic treatment market.
This report aims to provide a comprehensive presentation of the global market for Novel Oral Anticoagulants Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Novel Oral Anticoagulants Drugs.
Report Scope
The Novel Oral Anticoagulants Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Novel Oral Anticoagulants Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Novel Oral Anticoagulants Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bristol-Myers Squibb
Bayer
Pfizer
Johnson & Johnson
Boehringer Ingelheim
Daiichi Sankyo
Segment by Type
Direct Thrombin Inhibitor
Factor Xa Inhibitors
Segment by Application
Hospital
Drugs Stores
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Novel Oral Anticoagulants Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Novel Oral Anticoagulants Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Direct Thrombin Inhibitor
1.2.3 Factor Xa Inhibitors
1.3 Market by Application
1.3.1 Global Novel Oral Anticoagulants Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Drugs Stores
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Novel Oral Anticoagulants Drugs Market Perspective (2019-2030)
2.2 Novel Oral Anticoagulants Drugs Growth Trends by Region
2.2.1 Global Novel Oral Anticoagulants Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Novel Oral Anticoagulants Drugs Historic Market Size by Region (2019-2024)
2.2.3 Novel Oral Anticoagulants Drugs Forecasted Market Size by Region (2025-2030)
2.3 Novel Oral Anticoagulants Drugs Market Dynamics
2.3.1 Novel Oral Anticoagulants Drugs Industry Trends
2.3.2 Novel Oral Anticoagulants Drugs Market Drivers
2.3.3 Novel Oral Anticoagulants Drugs Market Challenges
2.3.4 Novel Oral Anticoagulants Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Novel Oral Anticoagulants Drugs Players by Revenue
3.1.1 Global Top Novel Oral Anticoagulants Drugs Players by Revenue (2019-2024)
3.1.2 Global Novel Oral Anticoagulants Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Novel Oral Anticoagulants Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Novel Oral Anticoagulants Drugs Revenue
3.4 Global Novel Oral Anticoagulants Drugs Market Concentration Ratio
3.4.1 Global Novel Oral Anticoagulants Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Novel Oral Anticoagulants Drugs Revenue in 2023
3.5 Novel Oral Anticoagulants Drugs Key Players Head office and Area Served
3.6 Key Players Novel Oral Anticoagulants Drugs Product Solution and Service
3.7 Date of Enter into Novel Oral Anticoagulants Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Novel Oral Anticoagulants Drugs Breakdown Data by Type
4.1 Global Novel Oral Anticoagulants Drugs Historic Market Size by Type (2019-2024)
4.2 Global Novel Oral Anticoagulants Drugs Forecasted Market Size by Type (2025-2030)
5 Novel Oral Anticoagulants Drugs Breakdown Data by Application
5.1 Global Novel Oral Anticoagulants Drugs Historic Market Size by Application (2019-2024)
5.2 Global Novel Oral Anticoagulants Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Novel Oral Anticoagulants Drugs Market Size (2019-2030)
6.2 North America Novel Oral Anticoagulants Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Novel Oral Anticoagulants Drugs Market Size by Country (2019-2024)
6.4 North America Novel Oral Anticoagulants Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Novel Oral Anticoagulants Drugs Market Size (2019-2030)
7.2 Europe Novel Oral Anticoagulants Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Novel Oral Anticoagulants Drugs Market Size by Country (2019-2024)
7.4 Europe Novel Oral Anticoagulants Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Novel Oral Anticoagulants Drugs Market Size (2019-2030)
8.2 Asia-Pacific Novel Oral Anticoagulants Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Novel Oral Anticoagulants Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Novel Oral Anticoagulants Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Novel Oral Anticoagulants Drugs Market Size (2019-2030)
9.2 Latin America Novel Oral Anticoagulants Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Novel Oral Anticoagulants Drugs Market Size by Country (2019-2024)
9.4 Latin America Novel Oral Anticoagulants Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Novel Oral Anticoagulants Drugs Market Size (2019-2030)
10.2 Middle East & Africa Novel Oral Anticoagulants Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Novel Oral Anticoagulants Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Novel Oral Anticoagulants Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Company Detail
11.1.2 Bristol-Myers Squibb Business Overview
11.1.3 Bristol-Myers Squibb Novel Oral Anticoagulants Drugs Introduction
11.1.4 Bristol-Myers Squibb Revenue in Novel Oral Anticoagulants Drugs Business (2019-2024)
11.1.5 Bristol-Myers Squibb Recent Development
11.2 Bayer
11.2.1 Bayer Company Detail
11.2.2 Bayer Business Overview
11.2.3 Bayer Novel Oral Anticoagulants Drugs Introduction
11.2.4 Bayer Revenue in Novel Oral Anticoagulants Drugs Business (2019-2024)
11.2.5 Bayer Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Novel Oral Anticoagulants Drugs Introduction
11.3.4 Pfizer Revenue in Novel Oral Anticoagulants Drugs Business (2019-2024)
11.3.5 Pfizer Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Detail
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Novel Oral Anticoagulants Drugs Introduction
11.4.4 Johnson & Johnson Revenue in Novel Oral Anticoagulants Drugs Business (2019-2024)
11.4.5 Johnson & Johnson Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Detail
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Novel Oral Anticoagulants Drugs Introduction
11.5.4 Boehringer Ingelheim Revenue in Novel Oral Anticoagulants Drugs Business (2019-2024)
11.5.5 Boehringer Ingelheim Recent Development
11.6 Daiichi Sankyo
11.6.1 Daiichi Sankyo Company Detail
11.6.2 Daiichi Sankyo Business Overview
11.6.3 Daiichi Sankyo Novel Oral Anticoagulants Drugs Introduction
11.6.4 Daiichi Sankyo Revenue in Novel Oral Anticoagulants Drugs Business (2019-2024)
11.6.5 Daiichi Sankyo Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
